September 22, 2023 @ 2:00 pm - September 23, 2023 @ 4:30 pm
World-renowned experts in the management of hematologic malignancies present the latest treatment advances, updates to the standard of care as recommended in the NCCN Guidelines®, and unique and challenging patient cases. Chaired by Andrew D. Zelenetz, MD, PhD, from Memorial Sloan Kettering Cancer Center, this program features presentations and interactive discussions highlighting the treatment options and supportive care for a variety of hematologic malignancies.
This program is approved for AMA PRA Category 1 Credit™ and ABIM, ABPath, and ABMS MOC for physicians and is also certified for credit for nurses, pharmacists, and other oncology professionals.
The NCCN 2023 Annual Congress: Hematologic MalignanciesTM is a hybrid event. Join us in-person or virtually for the same low registration fee. Please see Registration Fees for additional details.
Attend In-Person or Virtually!
In-person and virtual attendees will have full access to all pre-recorded online sessions, ability to attend all live sessions, opportunity to engage in interactive question and answer sessions with live speakers, and attend our NCCN Exhibition Hall.
Those attending in-person will have additional networking opportunities, including a Welcome Reception on Friday evening. Those attending onsite will also receive complimentary breakfast, lunch, and refreshments during breaks. Please see the Agenda tab for details (when available).
All content will be accessible for 60 days following the event for both in-person and virtual attendees, allowing time to review sessions you may have missed or revisit sessions important to your practice.
Share the Agenda and the Flyer with your colleagues!
333 O'Farrell Street San Francisco,
CA
94012+ Google Map
“As an oncologist practicing in a small group of five physicians, I need to stay informed of major developments in the business of oncology in order to effectively manage our practice. ANCO does an amazing job in sharing best practices and providing relevant, timely information. I also applaud ANCO for being the voice of Northern California Oncologists in its governmental advocacy work, which I have seen firsthand as a board member. Every oncologist in our region should be an ANCO member to continue to fortify our mission of providing quality care to all.”